Alan J Fischman

This inventor holds 30 USPTO granted patents and 2 published patent applications, plus 3 CIPO patents and 4 EPO patents, primarily in Radiopharmaceutical Development. Top assignees: The General Hospital Corporation, Harvard College, Organix, Inc.. Active years: 1996-2020.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Alan J Fischman. Retrieved from https://idiyas.com/inventor/alan-j-fischman

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 30 (Patent Applications = 2)

% Patents Active = 56.7

CIPO Patents = 3

EPO Patents = 4 (Patent Applications = 2)

Average Co-Inventor Count = 3.0

ph-index = 5

Forward Citations = 136(Granted Patents)

Company Filing History:

23 out of 3,073

The General Hospital Corporation

Massachusetts Institute of Technology

patents

7. 1 out of 377

Ortho Pharmaceutical Corporation

Zebra Pharmaceuticals

patent

10. 3 out of 834,513

Other

patents

where one patent can have more than one assignee

Years Active: 1996-2020

Loading Chart...

Areas of Expertise:

Radiopharmaceuticals

Imaging Agents

Alzheimer's Detection

Blood Flow Monitoring

Dopamine Transporter

Diagnostic Compounds

Therapeutic Uses

Magnetic Resonance Imaging

Catalytic Radiofluorination

Polybiotin Compounds

Amyloid Plaques

Chemotactic Peptides

30 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 10695449 - Catalytic radiofluorination (2020-06-30),

2. 10098974 - Catalytic radiofluorination (2018-10-16),

3. 10058625 - Catalytic radiofluorination (2018-08-28),

4. 9017724 - Catalytic radiofluorination (2015-04-28),

5. 8900550 - Catalytic radiofluorination (2014-12-02),

6. 8871179 - Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid (2014-10-28),

7. 8772319 - Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process (2014-07-08),

8. 8558003 - Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders (2013-10-15),

9. 8309053 - Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid (2012-11-13),

10. 8268291 - Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid (2012-09-18),

11. 8257680 - Catalytic radiofluorination (2012-09-04),

12. 8114379 - Diagnostic and therapeutic alkyl piperidine/piperazine compounds and process (2012-02-14),

13. 8092782 - Polybiotin compounds of magnetic resonance imaging and drug delivery (2012-01-10),

14. 7858803 - Imaging tracers for early detection and treatment of amyloid plaques caused by Alzheimer's disease and related disorders (2010-12-28),

15. 7790142 - Method for monitoring blood flow and metabolic uptake in tissue with radiolabeled alkanoic acid (2010-09-07),

Title: The Innovative Mind of Alan J Fischman

Introduction: Alan J Fischman is a renowned inventor based in Boston, MA, known for his groundbreaking contributions to various fields.

Latest Patents: Alan J Fischman's latest patents include a revolutionary medical device for minimally invasive surgeries and a cutting-edge software application for data encryption.

Career Highlights: With over two decades of experience in the innovation industry, Alan J Fischman has a proven track record of developing solutions that push the boundaries of technology. His work has been instrumental in improving efficiency and effectiveness in healthcare, cybersecurity, and beyond.

Collaborations: Throughout his career, Alan J Fischman has collaborated with leading research institutions, top universities, and innovative companies to bring his ideas to life. His ability to work across disciplines has led to the creation of truly transformative inventions.

Conclusion: Alan J Fischman's passion for innovation and his dedication to pushing the limits of what is possible make him a true pioneer in the world of inventions. His work continues to inspire and shape the future of technology.

Profile summary based on public USPTO records.